𝔖 Bobbio Scriptorium

✦ LIBER ✦

S49. Clinical activity and development of biomarkers for an engineered anti PDL1 antibody MPDL3280A

✍ Scribed by Cha, E

Book ID: 125405045
Publisher: Springer (Biomed Central Ltd.)
Year: 2014
Tongue: English
Weight: 72 KB
Volume: 2
Category: Article
ISSN: 2051-1426
DOI: 10.1186/2051-1426-2-S2-I21

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Intratumoral characteristics of tumor an

Intratumoral characteristics of tumor and immune cells at baseline and on-treatment correlated with clinical responses to MPDL3280A, an engineered antibody against PD-L1

✍ Holbrook Kohrt,Marcin Kowanetz,Scott Gettinger… 📂 Article 📅 2013 🏛 Springer (Biomed Central Ltd.) 🌐 English ⚖ 68 KB

Development of a quantitative cell-based

Development of a quantitative cell-based ELISA, for a humanized anti-IL-2/IL-15 receptor β antibody (HuMikβ1), and correlation with functional activity using an antigen-transfected murine cell line

✍ Xiao Yi Yang; Eying Chen; Hengguang Jiang; Wanda K. Hartmann; Gautam Mitra; Toby 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 332 KB

The development of an enzyme-linked immu

The development of an enzyme-linked immunosorbent assay (ELISA) for the detection of antibodies to retronecine: Mary A. Bober1, Mark J. Kurth1, Brian Miller1 and Michael Mount2 (1Departments of Chemistry and 2Clinical Pathology, University of California, Davis, CA 95616, U.S.A.)

📂 Article 📅 1989 🏛 Elsevier Science 🌐 English ⚖ 97 KB